Literature DB >> 34129813

ZNRF3 and RNF43 cooperate to safeguard metabolic liver zonation and hepatocyte proliferation.

Tianliang Sun1, Stefano Annunziato2, Sebastian Bergling2, Caibin Sheng2, Vanessa Orsini2, Pascal Forcella2, Monika Pikiolek2, Venkatesh Kancherla3, Sjoerd Holwerda2, Dilek Imanci2, Fabian Wu2, Ludivine Challet Meylan4, Lea F Puehringer2, Annick Waldt2, Mevion Oertli2, Sven Schuierer2, Luigi M Terracciano5, Stefan Reinker2, Heinz Ruffner2, Tewis Bouwmeester2, Andreas W Sailer2, Elizabeth George6, Guglielmo Roma2, Antoine de Weck2, Salvatore Piscuoglio3, Felix Lohmann2, Ulrike Naumann2, Prisca Liberali4, Feng Cong6, Jan S Tchorz7.   

Abstract

AXIN2 and LGR5 mark intestinal stem cells (ISCs) that require WNT/β-Catenin signaling for constant homeostatic proliferation. In contrast, AXIN2/LGR5+ pericentral hepatocytes show low proliferation rates despite a WNT/β-Catenin activity gradient required for metabolic liver zonation. The mechanisms restricting proliferation in AXIN2+ hepatocytes and metabolic gene expression in AXIN2+ ISCs remained elusive. We now show that restricted chromatin accessibility in ISCs prevents the expression of β-Catenin-regulated metabolic enzymes, whereas fine-tuning of WNT/β-Catenin activity by ZNRF3 and RNF43 restricts proliferation in chromatin-permissive AXIN2+ hepatocytes, while preserving metabolic function. ZNRF3 deletion promotes hepatocyte proliferation, which in turn becomes limited by RNF43 upregulation. Concomitant deletion of RNF43 in ZNRF3 mutant mice results in metabolic reprogramming of periportal hepatocytes and induces clonal expansion in a subset of hepatocytes, ultimately promoting liver tumors. Together, ZNRF3 and RNF43 cooperate to safeguard liver homeostasis by spatially and temporally restricting WNT/β-Catenin activity, balancing metabolic function and hepatocyte proliferation.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AXIN2+ hepatocytes; LGR5; R-Spondin; WNT signaling; hepatocellular carcinoma; instestinal stem cells; liver regeneration; liver zonation; metabolism; spatial transcriptomics

Mesh:

Substances:

Year:  2021        PMID: 34129813     DOI: 10.1016/j.stem.2021.05.013

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  4 in total

Review 1.  Molecular pathogenesis and systemic therapies for hepatocellular carcinoma.

Authors:  Josep M Llovet; Roser Pinyol; Robin K Kelley; Anthony El-Khoueiry; Helen L Reeves; Xin Wei Wang; Gregory J Gores; Augusto Villanueva
Journal:  Nat Cancer       Date:  2022-04-28

Review 2.  Unraveling the Complexity of Liver Disease One Cell at a Time.

Authors:  Gary D Bader; Ian D McGilvray; Sonya A MacParland; Jawairia Atif; Cornelia Thoeni
Journal:  Semin Liver Dis       Date:  2022-08-25       Impact factor: 6.512

3.  Transcriptomic and network pharmacology approaches revealed possible mechanisms underlying the 5-fluorouracil (5-FU)-sensitizing effect of Xuan-Fu-Hua decoction treatment on liver cancer cells.

Authors:  Wen-Zhao Luo; Zhong-Qin Dang; Xiu-Xia Wu; Yi-Wan Shang; Dan-Hua Meng; Yu-Long Chen; Qin-Sheng Zhang
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

4.  Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state.

Authors:  Veena Kochat; Ayush T Raman; Sharon M Landers; Ming Tang; Jonathan Schulz; Christopher Terranova; Jace P Landry; Angela D Bhalla; Hannah C Beird; Chia-Chin Wu; Yingda Jiang; Xizeng Mao; Rossana Lazcano; Swati Gite; Davis R Ingram; Min Yi; Jianhua Zhang; Emily Z Keung; Christopher P Scally; Christina L Roland; Kelly K Hunt; Barry W Feig; P Andrew Futreal; Patrick Hwu; Wei-Lien Wang; Alexander J Lazar; John M Slopis; Heather Wilson-Robles; Dominique J Wiener; Ian E McCutcheon; Brandan Wustefeld-Janssens; Kunal Rai; Keila E Torres
Journal:  Acta Neuropathol       Date:  2021-07-20       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.